Benjamin Gaborit
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antibiotic Resistance in Bacteria 6
- Co-authors
- David BoutoilleR. LecomteNathalie AsserayF. RaffiPaul Le TurnierChristine SaganMatthieu GrégoireRonan Bellouard
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Clinical Infectious Diseases (2 papers)International Journal of Infectious Diseases (2 papers)CHEST Journal (2 papers)
- Partner nations
- FranceCanadaUnited Kingdom
In The Last Decade
Benjamin Gaborit
42 papers receiving 535 citations
Peers
Comparison fields: 5 of 92
- Infectious Diseases 232
- Applied Microbiology and Biotechnology 20
- Clinical Biochemistry 52
- Critical Care and Intensive Care Medicine 36
- Molecular Medicine 31
Countries citing papers authored by Benjamin Gaborit
This map shows the geographic impact of Benjamin Gaborit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Gaborit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Gaborit more than expected).
Fields of papers citing papers by Benjamin Gaborit
This network shows the impact of papers produced by Benjamin Gaborit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Gaborit. The network helps show where Benjamin Gaborit may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Benjamin Gaborit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 14 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 21 | |
| 10 | 2022 | 0 | |
| 11 | 2022 | 14 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 12 | |
| 14 | 2020 | 47 | |
| 15 | 2020 | 14 | |
| 16 | 2020 | 20 | |
| 17 | 2020 | 21 | |
| 18 | 2019 | 43 | |
| 19 | 2018 | 53 | |
| 20 | 2018 | 9 |
About Benjamin Gaborit
Benjamin Gaborit is a scholar working on Microbiology, Molecular Medicine, Infectious Diseases, Applied Microbiology and Biotechnology and Epidemiology, having authored 47 papers that have together received 540 indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers), COVID-19 Clinical Research Studies (6 papers), Antibiotic Resistance in Bacteria (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). The work is most often cited by research in Infectious Diseases (232 citations), Applied Microbiology and Biotechnology (20 citations), Clinical Biochemistry (52 citations), Critical Care and Intensive Care Medicine (36 citations) and Molecular Medicine (31 citations). Benjamin Gaborit has collaborated with scholars based in France, Canada and United Kingdom. Frequent co-authors include David Boutoille, R. Lecomte, Nathalie Asseray, F. Raffi, Paul Le Turnier, Christine Sagan, Matthieu Grégoire, Ronan Bellouard, Emmanuel Canet and Colin Deschanvres. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, International Journal of Infectious Diseases and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.